Fujifilm to seek approval for Avigan in Covid-19 after positive data

Japan's Fujifilm Toyama Chemical plans to seek approval for its anti-viral drug Avigan (favipiravir) to...

Gerresheimer Group

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass...

Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies

South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at...

Advancing next-gen CD47 antibodies: AbbVie and I-Mab sign $1.94bn partnership

I-Mab and AbbVie have agreed a $1.94bn collaboration to develop and commercialise the former’s differentiated...

Aiming for perfection and zero defects in coronavirus vaccine development

Combination of Olumiant and Veklury has potential as Covid-19 treatment

India’s Dr Reddy’s signs deal for Russia’s Sputnik V Covid-19 vaccine

India-based pharmaceutical company Dr. Reddy’s Laboratories has partnered with the Russian Direct Investment Fund (RDIF)...

CII approves Carlyle’s acquisition of stake in Piramal Pharma for $490m

Fears of a second wave in the UK after a recent spike in Covid-19 cases

Exscientia and Huadong Medicine team up for AI-based drug discovery

Artificial intelligence (AI) drug discovery firm Exscientia has partnered with Chinese pharmaceutical company Huadong Medicine...